See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.36▲ 1.46%
← SM1 page
XStocksXray
Market X-Ray report · 27 October 2026

Synlait Milk Ltd (SM1)

Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026

Key indicators

Last closeAUD 0.420
52-week range0.285 – 0.660
Return, 1 month / 3 months+40.0% / +34.4%
Return, 1 year / 3 years−36.4% / −64.6%
TrendUptrend
RSI (14)72
Volatility (1 year)62.0%
Worst drawdown (1 year)-55.8%
Average daily value traded0.01M AUD
Dividend yield–

Market X-Ray price-based

57/ 100 · High confidence · ahead of 59% of stocks on this exchange
Trend67
Momentum66
Stability (higher is calmer)54
Liquidity33
Income–

Five-year price chart navy: price · brown: 200-day average

0.000.951.892.833.772021-112023-022024-052025-082026-10

About the company

Synlait Milk is a dairy processor based in Canterbury, New Zealand. It collects milk from dairy farms and turns it into ingredients and finished products, including infant formula, milk powders and specialised dairy ingredients. Much of its output is made for other branded dairy companies under contract, and it also produces its own consumer dairy products. Its customers are food companies and consumers in New Zealand and in export markets such as Asia.

Synlait Milk Ltd trades under the code SM1 on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Synlait Milk Ltd (SM1) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.420 on 27 October 2026.

Its price-based Market X-Ray is 57 out of 100 (a fair price profile), ranking 739 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 36.4% and over the last three months it rose 34.4%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Synlait Milk Ltd (SM1)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend67 · FairMixed trend against its averages.
Above 200-day average15.8%
From 52-week high-36.4%
Momentum66 · FairTypical recent returns for this exchange.
3-month return34.4%
6-month return13.5%
12-month return, skipping the last month-54.5%
Stability (higher is calmer)54 · FairTypical risk for this exchange.
Volatility, 1 year (lower is calmer)62.0%
Worst drawdown, 1 year (smaller is calmer)-55.8%
Liquidity33 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.01M AUD
Zero-volume days26.7%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week+18.3%
1 month+40.0%
3 months+34.4%
6 months+13.5%
1 year−36.4%
3 years−64.6%
5 years−87.6%

Signals

50-day / 200-day average0.335 / 0.363
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.018

Technical summary

DailyBullish12 bullish · 0 neutral · 4 bearish
WeeklyBullish7 bullish · 1 neutral · 4 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026